Twist Bioscience Corporation and Element Biosciences, Inc. announced on May 22, 2025, an expanded collaboration to integrate Twist's library preparation and target enrichment workflows with Element's AVITI systems and Trinity flowcells. This partnership aims to transform Next-Generation Sequencing (NGS) workflows with co-developed end-to-end solutions.
Under this expanded agreement, Twist will be the exclusive partner to develop additional library prep and target enrichment workflows compatible with Element’s Trinity sequencing technology. This provides Element customers with access to the uniformity, consistency, and quality of Twist's NGS tools.
The collaboration will also involve joint commercial and promotional activities to improve customer access to these innovative solutions. This strategic alliance is set to further advance Twist and Element's shared goal of streamlining hybrid capture processes and serving critical markets such as agbio, population genomics, and clinical research.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.